Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity

Multiple diagnostic tools are used to evaluate psoriasis and atopic dermatitis (AD) severity, but most of them are based on subjective components. Transepidermal water loss (TEWL) and temperature are skin barrier function parameters that can be objectively measured and could help clinicians to evalu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2021-01, Vol.10 (2), p.359
Hauptverfasser: Montero-Vilchez, Trinidad, Segura-Fernández-Nogueras, María-Victoria, Pérez-Rodríguez, Isabel, Soler-Gongora, Miguel, Martinez-Lopez, Antonio, Fernández-González, Ana, Molina-Leyva, Alejandro, Arias-Santiago, Salvador
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 359
container_title Journal of clinical medicine
container_volume 10
creator Montero-Vilchez, Trinidad
Segura-Fernández-Nogueras, María-Victoria
Pérez-Rodríguez, Isabel
Soler-Gongora, Miguel
Martinez-Lopez, Antonio
Fernández-González, Ana
Molina-Leyva, Alejandro
Arias-Santiago, Salvador
description Multiple diagnostic tools are used to evaluate psoriasis and atopic dermatitis (AD) severity, but most of them are based on subjective components. Transepidermal water loss (TEWL) and temperature are skin barrier function parameters that can be objectively measured and could help clinicians to evaluate disease severity accurately. Thus, the aims of this study are: (1) to compare skin barrier function between healthy skin, psoriatic skin and AD skin; and (2) to assess if skin barrier function parameters could predict disease severity. A cross-sectional study was designed, and epidermal barrier function parameters were measured. The study included 314 participants: 157 healthy individuals, 92 psoriatic patients, and 65 atopic dermatitis patients. TEWL was significantly higher, while stratum corneum hydration (SCH) (8.71 vs. 38.43 vs. 44.39 Arbitrary Units (AU)) was lower at psoriatic plaques than at uninvolved psoriatic skin and healthy controls. Patients with both TEWL > 13.85 g·m h and temperature > 30.85 °C presented a moderate/severe psoriasis (psoriasis area severity index (PASI) ≥ 7), with a specificity of 76.3%. TEWL (28.68 vs. 13.15 vs. 11.60 g·m h ) and temperature were significantly higher, while SCH (25.20 vs. 40.95 vs. 50.73 AU) was lower at AD eczematous lesions than uninvolved AD skin and healthy controls. Patients with a temperature > 31.75 °C presented a moderate/severe AD (SCORing Atopic Dermatitis (SCORAD) ≥ 37) with a sensitivity of 81.8%. In conclusion, temperature and TEWL values may help clinicians to determine disease severity and select patients who need intensive treatment.
doi_str_mv 10.3390/jcm10020359
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7833436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480431473</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-387eac56ded6cb1aebda4ea5172791ea06207f0569dcc43cbea854989b71bd7c3</originalsourceid><addsrcrecordid>eNpdkVFrFDEQx4NYbKl98l0Cvghymmyym10fhLO1KhxU6BUfw2x2TnPubraZbKFfop_ZlKvlbF4mzPzmz8z8GXslxXulGvFh6wYpRCFU2TxjR4UwZiFUrZ7v_Q_ZCdFW5FfXupDmBTtUShvTaH3E7i7_-JF_hhg9Rn4-jy75MPKc-0EheiBPHMaOL1OYvONnGAdIPnn6yNcRRsLJd_e5nv-ElBVWgXYNaxwmjJDmiByIXxFu5p6vQ-iJp8CXRJjJM08IhPwSbzD6dPuSHWygJzx5iMfs6vzL-vTbYnXx9fvpcrVw2pRpoWqD4Mqqw65yrQRsO9AIpTSFaSSCqPL2G1FWTeecVq5FqEvd1E1rZNsZp47Zp53uNLcDdg7HFKG3U_QDxFsbwNv_K6P_bX-FG2vqfDtVZYG3DwIxXM9IyQ6eHPY9jBhmsoWuhVZSG5XRN0_QbZjjmNezRaWl0MIokal3O8rFfMKIm8dhpLD3Vts9qzP9en_-R_afseovjLCnPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641040730</pqid></control><display><type>article</type><title>Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Montero-Vilchez, Trinidad ; Segura-Fernández-Nogueras, María-Victoria ; Pérez-Rodríguez, Isabel ; Soler-Gongora, Miguel ; Martinez-Lopez, Antonio ; Fernández-González, Ana ; Molina-Leyva, Alejandro ; Arias-Santiago, Salvador</creator><creatorcontrib>Montero-Vilchez, Trinidad ; Segura-Fernández-Nogueras, María-Victoria ; Pérez-Rodríguez, Isabel ; Soler-Gongora, Miguel ; Martinez-Lopez, Antonio ; Fernández-González, Ana ; Molina-Leyva, Alejandro ; Arias-Santiago, Salvador</creatorcontrib><description>Multiple diagnostic tools are used to evaluate psoriasis and atopic dermatitis (AD) severity, but most of them are based on subjective components. Transepidermal water loss (TEWL) and temperature are skin barrier function parameters that can be objectively measured and could help clinicians to evaluate disease severity accurately. Thus, the aims of this study are: (1) to compare skin barrier function between healthy skin, psoriatic skin and AD skin; and (2) to assess if skin barrier function parameters could predict disease severity. A cross-sectional study was designed, and epidermal barrier function parameters were measured. The study included 314 participants: 157 healthy individuals, 92 psoriatic patients, and 65 atopic dermatitis patients. TEWL was significantly higher, while stratum corneum hydration (SCH) (8.71 vs. 38.43 vs. 44.39 Arbitrary Units (AU)) was lower at psoriatic plaques than at uninvolved psoriatic skin and healthy controls. Patients with both TEWL &gt; 13.85 g·m h and temperature &gt; 30.85 °C presented a moderate/severe psoriasis (psoriasis area severity index (PASI) ≥ 7), with a specificity of 76.3%. TEWL (28.68 vs. 13.15 vs. 11.60 g·m h ) and temperature were significantly higher, while SCH (25.20 vs. 40.95 vs. 50.73 AU) was lower at AD eczematous lesions than uninvolved AD skin and healthy controls. Patients with a temperature &gt; 31.75 °C presented a moderate/severe AD (SCORing Atopic Dermatitis (SCORAD) ≥ 37) with a sensitivity of 81.8%. In conclusion, temperature and TEWL values may help clinicians to determine disease severity and select patients who need intensive treatment.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm10020359</identifier><identifier>PMID: 33477944</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Clinical medicine ; Dermatitis ; Dermatology ; Eczema ; Erythema ; Family medical history ; Homeostasis ; Psoriasis ; Skin diseases</subject><ispartof>Journal of clinical medicine, 2021-01, Vol.10 (2), p.359</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-387eac56ded6cb1aebda4ea5172791ea06207f0569dcc43cbea854989b71bd7c3</citedby><cites>FETCH-LOGICAL-c475t-387eac56ded6cb1aebda4ea5172791ea06207f0569dcc43cbea854989b71bd7c3</cites><orcidid>0000-0001-6882-2113 ; 0000-0003-4035-7955 ; 0000-0001-6852-0836 ; 0000-0002-4186-1435</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833436/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833436/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33477944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montero-Vilchez, Trinidad</creatorcontrib><creatorcontrib>Segura-Fernández-Nogueras, María-Victoria</creatorcontrib><creatorcontrib>Pérez-Rodríguez, Isabel</creatorcontrib><creatorcontrib>Soler-Gongora, Miguel</creatorcontrib><creatorcontrib>Martinez-Lopez, Antonio</creatorcontrib><creatorcontrib>Fernández-González, Ana</creatorcontrib><creatorcontrib>Molina-Leyva, Alejandro</creatorcontrib><creatorcontrib>Arias-Santiago, Salvador</creatorcontrib><title>Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Multiple diagnostic tools are used to evaluate psoriasis and atopic dermatitis (AD) severity, but most of them are based on subjective components. Transepidermal water loss (TEWL) and temperature are skin barrier function parameters that can be objectively measured and could help clinicians to evaluate disease severity accurately. Thus, the aims of this study are: (1) to compare skin barrier function between healthy skin, psoriatic skin and AD skin; and (2) to assess if skin barrier function parameters could predict disease severity. A cross-sectional study was designed, and epidermal barrier function parameters were measured. The study included 314 participants: 157 healthy individuals, 92 psoriatic patients, and 65 atopic dermatitis patients. TEWL was significantly higher, while stratum corneum hydration (SCH) (8.71 vs. 38.43 vs. 44.39 Arbitrary Units (AU)) was lower at psoriatic plaques than at uninvolved psoriatic skin and healthy controls. Patients with both TEWL &gt; 13.85 g·m h and temperature &gt; 30.85 °C presented a moderate/severe psoriasis (psoriasis area severity index (PASI) ≥ 7), with a specificity of 76.3%. TEWL (28.68 vs. 13.15 vs. 11.60 g·m h ) and temperature were significantly higher, while SCH (25.20 vs. 40.95 vs. 50.73 AU) was lower at AD eczematous lesions than uninvolved AD skin and healthy controls. Patients with a temperature &gt; 31.75 °C presented a moderate/severe AD (SCORing Atopic Dermatitis (SCORAD) ≥ 37) with a sensitivity of 81.8%. In conclusion, temperature and TEWL values may help clinicians to determine disease severity and select patients who need intensive treatment.</description><subject>Clinical medicine</subject><subject>Dermatitis</subject><subject>Dermatology</subject><subject>Eczema</subject><subject>Erythema</subject><subject>Family medical history</subject><subject>Homeostasis</subject><subject>Psoriasis</subject><subject>Skin diseases</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkVFrFDEQx4NYbKl98l0Cvghymmyym10fhLO1KhxU6BUfw2x2TnPubraZbKFfop_ZlKvlbF4mzPzmz8z8GXslxXulGvFh6wYpRCFU2TxjR4UwZiFUrZ7v_Q_ZCdFW5FfXupDmBTtUShvTaH3E7i7_-JF_hhg9Rn4-jy75MPKc-0EheiBPHMaOL1OYvONnGAdIPnn6yNcRRsLJd_e5nv-ElBVWgXYNaxwmjJDmiByIXxFu5p6vQ-iJp8CXRJjJM08IhPwSbzD6dPuSHWygJzx5iMfs6vzL-vTbYnXx9fvpcrVw2pRpoWqD4Mqqw65yrQRsO9AIpTSFaSSCqPL2G1FWTeecVq5FqEvd1E1rZNsZp47Zp53uNLcDdg7HFKG3U_QDxFsbwNv_K6P_bX-FG2vqfDtVZYG3DwIxXM9IyQ6eHPY9jBhmsoWuhVZSG5XRN0_QbZjjmNezRaWl0MIokal3O8rFfMKIm8dhpLD3Vts9qzP9en_-R_afseovjLCnPw</recordid><startdate>20210119</startdate><enddate>20210119</enddate><creator>Montero-Vilchez, Trinidad</creator><creator>Segura-Fernández-Nogueras, María-Victoria</creator><creator>Pérez-Rodríguez, Isabel</creator><creator>Soler-Gongora, Miguel</creator><creator>Martinez-Lopez, Antonio</creator><creator>Fernández-González, Ana</creator><creator>Molina-Leyva, Alejandro</creator><creator>Arias-Santiago, Salvador</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6882-2113</orcidid><orcidid>https://orcid.org/0000-0003-4035-7955</orcidid><orcidid>https://orcid.org/0000-0001-6852-0836</orcidid><orcidid>https://orcid.org/0000-0002-4186-1435</orcidid></search><sort><creationdate>20210119</creationdate><title>Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity</title><author>Montero-Vilchez, Trinidad ; Segura-Fernández-Nogueras, María-Victoria ; Pérez-Rodríguez, Isabel ; Soler-Gongora, Miguel ; Martinez-Lopez, Antonio ; Fernández-González, Ana ; Molina-Leyva, Alejandro ; Arias-Santiago, Salvador</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-387eac56ded6cb1aebda4ea5172791ea06207f0569dcc43cbea854989b71bd7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Clinical medicine</topic><topic>Dermatitis</topic><topic>Dermatology</topic><topic>Eczema</topic><topic>Erythema</topic><topic>Family medical history</topic><topic>Homeostasis</topic><topic>Psoriasis</topic><topic>Skin diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montero-Vilchez, Trinidad</creatorcontrib><creatorcontrib>Segura-Fernández-Nogueras, María-Victoria</creatorcontrib><creatorcontrib>Pérez-Rodríguez, Isabel</creatorcontrib><creatorcontrib>Soler-Gongora, Miguel</creatorcontrib><creatorcontrib>Martinez-Lopez, Antonio</creatorcontrib><creatorcontrib>Fernández-González, Ana</creatorcontrib><creatorcontrib>Molina-Leyva, Alejandro</creatorcontrib><creatorcontrib>Arias-Santiago, Salvador</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montero-Vilchez, Trinidad</au><au>Segura-Fernández-Nogueras, María-Victoria</au><au>Pérez-Rodríguez, Isabel</au><au>Soler-Gongora, Miguel</au><au>Martinez-Lopez, Antonio</au><au>Fernández-González, Ana</au><au>Molina-Leyva, Alejandro</au><au>Arias-Santiago, Salvador</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2021-01-19</date><risdate>2021</risdate><volume>10</volume><issue>2</issue><spage>359</spage><pages>359-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Multiple diagnostic tools are used to evaluate psoriasis and atopic dermatitis (AD) severity, but most of them are based on subjective components. Transepidermal water loss (TEWL) and temperature are skin barrier function parameters that can be objectively measured and could help clinicians to evaluate disease severity accurately. Thus, the aims of this study are: (1) to compare skin barrier function between healthy skin, psoriatic skin and AD skin; and (2) to assess if skin barrier function parameters could predict disease severity. A cross-sectional study was designed, and epidermal barrier function parameters were measured. The study included 314 participants: 157 healthy individuals, 92 psoriatic patients, and 65 atopic dermatitis patients. TEWL was significantly higher, while stratum corneum hydration (SCH) (8.71 vs. 38.43 vs. 44.39 Arbitrary Units (AU)) was lower at psoriatic plaques than at uninvolved psoriatic skin and healthy controls. Patients with both TEWL &gt; 13.85 g·m h and temperature &gt; 30.85 °C presented a moderate/severe psoriasis (psoriasis area severity index (PASI) ≥ 7), with a specificity of 76.3%. TEWL (28.68 vs. 13.15 vs. 11.60 g·m h ) and temperature were significantly higher, while SCH (25.20 vs. 40.95 vs. 50.73 AU) was lower at AD eczematous lesions than uninvolved AD skin and healthy controls. Patients with a temperature &gt; 31.75 °C presented a moderate/severe AD (SCORing Atopic Dermatitis (SCORAD) ≥ 37) with a sensitivity of 81.8%. In conclusion, temperature and TEWL values may help clinicians to determine disease severity and select patients who need intensive treatment.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33477944</pmid><doi>10.3390/jcm10020359</doi><orcidid>https://orcid.org/0000-0001-6882-2113</orcidid><orcidid>https://orcid.org/0000-0003-4035-7955</orcidid><orcidid>https://orcid.org/0000-0001-6852-0836</orcidid><orcidid>https://orcid.org/0000-0002-4186-1435</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2021-01, Vol.10 (2), p.359
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7833436
source PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Clinical medicine
Dermatitis
Dermatology
Eczema
Erythema
Family medical history
Homeostasis
Psoriasis
Skin diseases
title Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T08%3A22%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Skin%20Barrier%20Function%20in%20Psoriasis%20and%20Atopic%20Dermatitis:%20Transepidermal%20Water%20Loss%20and%20Temperature%20as%20Useful%20Tools%20to%20Assess%20Disease%20Severity&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Montero-Vilchez,%20Trinidad&rft.date=2021-01-19&rft.volume=10&rft.issue=2&rft.spage=359&rft.pages=359-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm10020359&rft_dat=%3Cproquest_pubme%3E2480431473%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2641040730&rft_id=info:pmid/33477944&rfr_iscdi=true